Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Targeting BRCA1-and BRCA2-deficient cells with RAD52 small molecule inhibitors
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting BRCA1-and BRCA2-deficient cells with RAD52 small molecule inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Small Molecule Inhibitors
100%
RAD52
100%
BRCA1, BRCA2
100%
Single-stranded DNA (ssDNA)
22%
Annealing
22%
Cancer Therapy
11%
RAD51
11%
Novel Therapeutics
11%
Homologous Recombination Pathway
11%
Ovarian Cancer
11%
Single-strand Annealing
11%
Genome Integrity
11%
Fluorescence Quenching Assay
11%
DNA Strand Exchange
11%
Hereditary Breast Cancer
11%
PALB2
11%
Biochemical Activity
11%
Compound Library
11%
DNA Repair
11%
Human Cells
11%
Cell-based
11%
Biochemistry, Genetics and Molecular Biology
BRCA1
100%
RAD52
100%
Small Molecule
100%
BRCA2
100%
Homologous Recombination
11%
RAD51C
11%
DNA Repair
11%
DNA Strand
11%
Quenching (Fluorescence)
11%
PALB2
11%